These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 16504673

  • 1. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L.
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M.
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [Abstract] [Full Text] [Related]

  • 3. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M.
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [Abstract] [Full Text] [Related]

  • 4. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
    Bouzas L, Ortega FJ, Casado P, Arranz MI, Carcas A, Tutor JC.
    Clin Lab; 2007 Jun; 53(9-12):591-6. PubMed ID: 18257466
    [Abstract] [Full Text] [Related]

  • 5. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 6. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
    Hermida J, Tutor JC.
    Clin Lab; 2003 Oct; 49(9-10):471-4. PubMed ID: 14572203
    [Abstract] [Full Text] [Related]

  • 7. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK, Chang HK, Kim HJ, Huh KH, Ahn HJ, Kim MS, Kim SI, Kim YS.
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S, Nagano H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Monden M, Doki Y, Mori M.
    J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
    [Abstract] [Full Text] [Related]

  • 9. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
    Bachetoni A, Mariani P, D'Alessandro M, Baiano V, Appodia C, Collepardo D, Berloco P.
    Transplant Proc; 2007 Jun; 39(6):2008-9. PubMed ID: 17692678
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R, Chusney G, Loucaidou M, James A, Stichbury J, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D.
    Ther Drug Monit; 2006 Apr 01; 28(2):269-73. PubMed ID: 16628143
    [Abstract] [Full Text] [Related]

  • 12. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar 01; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of hematocrit interference in the tacrolimus II microparticle enzyme immunoassay: a tentative approach.
    Hermida J, Fernández MC, Tutor JC.
    Clin Lab; 2005 Mar 01; 51(1-2):43-5. PubMed ID: 15719703
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F, Lorf T, Schütz E, Christians U, Grupp C, Sattler B, Canelo R, Sewing KF, Armstrong VW, Oellerich M, Ringe B.
    Transplant Proc; 1996 Dec 01; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients.
    Huet E, Morand K, Blanchet B, Astier A, Hulin A.
    Transplant Proc; 2004 Jun 01; 36(5):1317-20. PubMed ID: 15251322
    [Abstract] [Full Text] [Related]

  • 16. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
    Rostaing L, Cointault O, Marquet P, Josse AG, Lavit M, Saint-Marcoux F, Kamar N.
    Transpl Int; 2010 Feb 01; 23(2):227-30. PubMed ID: 19761555
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay.
    Borrows R, Chusney G, Loucaidou M, Singh S, James A, Stichbury J, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D.
    Transplant Proc; 2005 May 01; 37(4):1733-5. PubMed ID: 15919448
    [Abstract] [Full Text] [Related]

  • 18. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
    Tomita T, Homma M, Yuzawa K, Ohkohchi N, Hori T, Kaneko M, Hasegawa Y, Kojima H, Nagasawa T, Kohda Y.
    Ther Drug Monit; 2005 Feb 01; 27(1):94-7. PubMed ID: 15665753
    [Abstract] [Full Text] [Related]

  • 19. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B, Taieb F, Conti F, Abbas H, Seydi I, Harcouet L, Dauphin A, Calmus Y, Tod M.
    Liver Transpl; 2008 Dec 01; 14(12):1745-51. PubMed ID: 19025918
    [Abstract] [Full Text] [Related]

  • 20. [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer].
    Yargui L, Berhoune A.
    Ann Biol Clin (Paris); 2008 Dec 01; 66(6):657-64. PubMed ID: 19091665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.